The effects of IL-1 receptor antagonist on beta amyloid mediated depression of LTP in the rat CA1 in vivo

Hippocampus

Volumn 19, Issue 7, 2009, Pages 670-676

  Schmid, Adrien W ^b   Lynch, Marina A ^a   Herron, Caroline E ^c  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b EPFL   (Switzerland)

^c UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

Beta amyloid peptide; IL 1ra; In vivo; Long term potentiation; LTP

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN PROTECTION; BRAIN TOXICITY; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FACILITATION; LONG TERM DEPRESSION; LONG TERM POTENTIATION; MALE; NERVE CELL PLASTICITY; NONHUMAN; POST TETANIC POTENTIATION; PRIORITY JOURNAL; RAT; SYNAPTIC TRANSMISSION;

AMYLOID BETA-PROTEIN; ANALYSIS OF VARIANCE; ANIMALS; ELECTRIC STIMULATION; ELECTRODES, IMPLANTED; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LONG-TERM POTENTIATION; MALE; PEPTIDE FRAGMENTS; PROBABILITY; RATS; RATS, WISTAR; TIME FACTORS;

EID: 67649646784     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20542     Document Type: Article

References (43)

1. Alstergren P, Benavente C, Kopp S. 2003. Interleukin-1beta, interleukin-1 receptor antagonist, and interleukin-1 soluble receptor II in temporomandibular joint synovial fluid from patients with chronic polyarthritides. J Oral Maxillofac Surg 61:1171-1178. (Pubitemid 37193494)
2. Avital A, Goshen I, Kamsler A, Segal M, Iverfeldt K, Richter-Levin G, Yirmiya R. 2003. Impaired interleukin-1 signaling is associated with deficits in hippocampal memory processes and neural plasticity. Hippocampus 13:826-834. (Pubitemid 37407969)
3. Bellinger FP, Madamba S, Siggins GR. 1993. Interleukin 1 beta inhibits synaptic strength and long-term potentiation in the rat CA1 hippocampus. Brain Res 628:227-234. (Pubitemid 2012690)
4. Bliss TV, Collingridge GL. 1993. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 361:31-39. (Pubitemid 23020772)
5. Brennan FX, Beck KD, Servatius RJ. 2003. Low doses of interleukin-1beta improve the leverpress avoidance performance of Sprague-Dawley rats. Neurobiol Learn Mem 80:168-171. (Pubitemid 36970238)
6. Coogan AN, O'Neill LA, O'Connor JJ. 1999. The P38 mitogen-activated protein kinase inhibitor SB203580 antagonizes the inhibitory effects of interleukin-1beta on long-term potentiation in the rat dentate gyrus in vitro. Neuroscience 93:57-69. (Pubitemid 29290686)
7. Costello DA, Herron CE. 2004. The role of c-Jun N-terminal kinase in the A beta-mediated impairment of LTP and regulation of synaptic transmission in the hippocampus. Neuropharmacology 46:655-662. (Pubitemid 38292970)
8. Costello DA, O'Leary DM, Herron CE. 2005. Agonists of peroxisome proliferator-activated receptor-gamma attenuate the Abeta-mediated impairment of LTP in the hippocampus in vitro. Neuropharmacology 49:359-366. (Pubitemid 41112823)
9. Craft JM, Watterson DM, Hirsch E, Van Eldik LJ. 2005. Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human beta-amyloid. J Neuroinflammation 2:15. (Pubitemid 41522073)
10. Cunningham AJ, Murray CA, O'Neill LA, Lynch MA, O'Connor JJ. 1996. Interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) inhibit long-term potentiation in the rat dentate gyrus in vitro. Neurosci Lett 203:17-20. (Pubitemid 126335006)
11. Dinarello CA. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095-2147. (Pubitemid 26086851)
12. Freir DB, Herron CE. 2003. Nicotine enhances the depressive actions of A beta 1-40 on long-term potentiation in the rat hippocampal CA1 region in vivo. J Neurophysiol 89:2917-2922. (Pubitemid 36682644)
13. Freir DB, Costello DA, Herron CE. 2003. A beta 25-35-induced depression of long-term potentiation in area CA1 in vivo and in vitro is attenuated by verapamil. J Neurophysiol 89:3061-3069. (Pubitemid 36682658)
14. Frick A, Magee J, Johnston D. 2004. LTP is accompanied by an enhanced local excitability of pyramidal neuron dendrites. Nat Neurosci 7:126-135. (Pubitemid 38129788)
15. Hailer NP, Vogt C, Korf HW, Dehghani F. 2005. Interleukin-1beta exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures. Eur J Neurosci 21:2347-2360. (Pubitemid 40813918)
16. Hannum CH, Wilcox CJ, Arend WP, Joslin FG, Dripps DJ, Heimdal PL, Armes LG, Sommer A, Eisenberg SP, Thompson RC. 1990. Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor. Nature 343:336-340. (Pubitemid 120028524)
17. Huber KM, Gallagher SM, Warren ST, Bear MF. 2002. Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99:7746-7750. (Pubitemid 34568762)
18. Jacobsen JS, Wu CC, Redwine JM, Comery TA, Arias R, Bowlby M, Martone R, Morrison JH, Pangalos MN, Reinhart PH, Bloom FE. 2006. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 103:5161-5166.
19. Katsuki H, Nakai S, Hirai Y, Akaji K, Kiso Y, Satoh M. 1990. Interleukin-1 beta inhibits long-term potentiation in the CA3 region of mouse hippocampal slices. Eur J Pharmacol 181:323-326. (Pubitemid 20185911)
20. Klyubin I, Walsh DM, Cullen WK, Fadeeva JV, Anwyl R, Selkoe DJ, Rowan MJ. 2004. Soluble Arctic amyloid beta protein inhibits hippocampal long-term potentiation in vivo. Eur J Neurosci 19:2839-2846. (Pubitemid 38746400)
21. Lai YL, Smith PM, Lamm WJ, Hildebrandt J. 1983. Sampling and analysis of cerebrospinal fluid for chronic studies in awake rats. J Appl Physiol 54:1754-1757.
22. Lauri SE, Palmer M, Segerstrale M, Vesikansa A, Taira T, Collingridge GL. 2007. Presynaptic mechanisms involved in the expression of STP and LTP at CA1 synapses in the hippocampus. Neuropharmacology 52:1-11. (Pubitemid 46026817)
23. Lindberg C, Selenica ML, Westlind-Danielsson A, Schultzberg M. 2005. Beta-amyloid protein structure determines the nature of cytokine release from rat microglia. J Mol Neurosci 27:1-12. (Pubitemid 41112374)
24. Loscher CE, Mills KH, Lynch MA. 2003. Interleukin-1 receptor antagonist exerts agonist activity in the hippocampus independent of the interleukin-1 type I receptor. J Neuroimmunol 137:117-124. (Pubitemid 36351573)
25. Lynch MA. 2004. Long-term potentiation and memory. Physiol Rev 84:87-136. (Pubitemid 38049877)
26. MacManus A, Ramsden M, Murray M, Henderson Z, Pearson HA, Campbell VA. 2000. Enhancement of (45)Ca(2+) influx and voltage-dependent Ca(2+) channel activity by beta-amyloid-(1-40) in rat cortical synaptosomes and cultured cortical neurons. Modulation by the proinflammatory cytokine interleukin-1beta. J Biol Chem 275:4713-4718.
27. Mattson MP. 1997. Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol Rev 77:1081-1132. (Pubitemid 27459580)
28. Meek JL, Neff NH. 1973. Is cerebrospinal fluid the major avenue for the removal of 5-hydroxyindoleacetic acid from the brain? Neuropharmacology 12:497-499.
29. Minogue AM, Schmid AW, Fogarty MP, Moore AC, Campbell VA, Herron CE, Lynch MA. 2003. Activation of the c-Jun N-terminal kinase signaling cascade mediates the effect of amyloid-beta on long term potentiation and cell death in hippocampus: A role for interleukin-1beta? J Biol Chem 278:27971-27980. (Pubitemid 36899992)
30. Murray CA, McGahon B, McBennett S, Lynch MA. 1997. Interleukin-1 beta inhibits glutamate release in hippocampus of young, but not aged, rats. Neurobiol Aging 18:343-348. (Pubitemid 27360072)
31. Panegyres PK, Hughes J. 1998. The neuroprotective effects of the recombinant interleukin-1 receptor antagonist rhIL-1ra after excitotoxic stimulation with kainic acid and its relationship to the amyloid precursor protein gene. J Neurol Sci 154:123-132. (Pubitemid 28156927)
32. Parnet P, Amindari S, Wu C, Brunke-Reese D, Goujon E, Weyhenmeyer JA, Dantzer R, Kelley KW. 1994. Expression of type I and type II interleukin-1 receptors in mouse brain. Brain Res Mol Brain Res 27:63-70. (Pubitemid 24324090)
33. Parvathenani LK, Tertyshnikova S, Greco CR, Roberts SB, Robertson B, Posmantur R. 2003. P2X7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J Biol Chem 278:13309-13317. (Pubitemid 36800102)
34. Ross FM, Allan SM, Rothwell NJ, Verkhratsky A. 2003. A dual role for interleukin-1 in LTP in mouse hippocampal slices. J Neuroimmunol 144:61-67. (Pubitemid 37329930)
35. Schafers M, Sorkin L. 2008. Effect of cytokines on neuronal excitability. Neurosci Lett 437:188-193.
36. Schmid AW, Freir DB, Herron CE. 2008. Inhibition of LTP in vivo by beta-amyloid peptide in different conformational states. Brain Res 1197:135-142.
37. Schneider H, Pitossi F, Balschun D, Wagner A, del Rey A, Besedovsky HO. 1998. A neuromodulatory role of interleukin-1beta in the hippocampus. Proc Natl Acad Sci USA 95:7778-7783.
38. Schreuder H, Tardif C, Trump-Kallmeyer S, Soffientini A, Sarubbi E, Akeson A, Bowlin T, Yanofsky S, Barrett RW. 1997. A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonist. Nature 386:194-200. (Pubitemid 27131449)
39. Schulz PE, Cook EP, Johnston D. 1994. Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation. J Neurosci 14:5325-5337. (Pubitemid 24279053)
40. Sims JE, Gayle MA, Slack JL, Alderson MR, Bird TA, Giri JG, Colotta F, Re F, Mantovani A, Shanebeck K, Grabstein KH, Dower SJ. 1993. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc Natl Acad Sci USA 90:6155-6159. (Pubitemid 23191473)
41. Vigers GP, Anderson LJ, Caffes P, Brandhuber BJ. 1997. Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1beta. Nature 386:190-194. (Pubitemid 27131448)
42. Viviani B, Bartesaghi S, Gardoni F, Vezzani A, Behrens MM, Bartfai T, Binaglia M, Corsini E, Di Luca M, Galli CL, Marinovich M. 2003. Interleukin-1beta enhances NMDA receptor-mediated intracellular calcium increase through activation of the Src family of kinases. J Neurosci 23:8692-8700. (Pubitemid 37176649)
43. Yirmiya R, Winocur G, Goshen I. 2002. Brain interleukin-1 is involved in spatial memory and passive avoidance conditioning. Neurobiol Learn Mem 78:379-389. (Pubitemid 35366017)